2m 2m 2m 2m 2m 2m 2m
KYMERA THERAP (KYMR)
NASDAQ
$135.69-$0.95 (-0.70%)
Price as of Nov 11, 2026 7:30 PM EST- $11.7BMarket Cap
- 115.62%1-Year Change
- BiotechnologyIndustry
KYMERA THERAP (KYMR)
$135.69-$0.95 (-0.70%)
KYMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $136.64 | ||
Change | -$2.22 (-1.60%) | ||
Open | $138.86 | ||
High | $142.92 | ||
Low | $136.01 | ||
Previous Close | $138.86 | ||
Volume | 995,591 | ||
30-Day Average Volume | 975,069 | ||
1-Week Change | 7.51% | ||
1-Month Change | 21.57% | ||
1-Year Change | 115.62% | ||
3-Year Change | 841.05% | ||
5-Year Change | 114.04% | ||
Fundamentals | |||
Shares Outstanding | 85.4M | ||
Total Assets | $1.8B | ||
Market Cap | $11.7B | ||
Enterprise Value | $11.3B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$132.0M | ||
Free Cash Flow | -$78.2M | ||
EBIT | -$131.9M | ||
EBITDA | -$129.9M | ||
Net Working Capital | $908.9M | ||
EPS | -$1.32 | ||
Enterprise Value/EBITDA | -87 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -104 | ||
PEG | 1 | ||
Price/Free Cash Flow | -149 | ||
Price/Operating Cash Flow | -150 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue